Forums
New posts
Search forums
What's new
New posts
New media
New media comments
Latest activity
Classifieds
Media
New media
New comments
Search media
Log in
Register
What's New?
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More Options
Advertise with us
Contact Us
Close Menu
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Forums
The Water Cooler
General Discussion
Why wasn't this known sooner??? Covid drug around since 1979
Search titles only
By:
Reply to Thread
This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
Message
<blockquote data-quote="dennishoddy" data-source="post: 3656247" data-attributes="member: 5412"><p>There was a news story today about the new "pill" that can be taken to treat off the covid if taken early floating around this morning. It costs penny's to make.</p><p>The company, I believe it was Merck said they were going to market it at over $700. Meanwhile the generic of it is going to be sold in India at $19.</p><p>Found it:</p><p><strong>The New Jersey-based pharmaceutical</strong> giant Merck is facing accusations of price gouging after it charged the U.S. <a href="https://www.nytimes.com/2021/10/01/business/covid-antiviral-pill-merck.html" target="_blank">over $700 per patient</a> for a <a href="https://theintercept.com/2021/10/05/covid-pill-drug-pricing-merck-ridgeback/" target="_blank">taxpayer-funded</a> coronavirus treatment that, according to research, costs just $17.74 to produce.</p><p></p><p><strong>Your tax dollars are paying for this even though brain dead biden says it's free if approved.</strong></p><p></p><p>Last week, Merck <a href="https://www.nbcnews.com/health/health-news/merck-says-experimental-covid-pill-cuts-risk-death-hospitalization-50-n1280536" target="_blank">announced</a> plans to request emergency federal authorization for molnupiravir after a late-stage clinical trial <a href="https://www.ft.com/content/e1a059dc-ab09-47c0-b7b9-2b79dd1c911b" target="_blank">showed</a> that a five-day course of the antiviral drug cut the risk of Covid-19 hospitalization or death in half in patients with mild-to-moderate cases.</p><p></p><p>The same day Merck unveiled the results of the trial and White House officials hailed the drug as another possible tool against Covid-19, the <em>New York Times</em> <a href="https://www.nytimes.com/2021/10/01/business/covid-antiviral-pill-merck.html" target="_blank">reported</a> that "the federal government has placed advance orders for 1.7 million courses of treatment, at a price of about $700 per patient"—far more than the estimated cost of manufacturing the drug.</p><p></p><p>According to an <a href="https://scholar.harvard.edu/files/melissabarber/files/estimated_cost-based_generic_prices_for_molnupiravir_for_the_treatment_of_covid-19_infection.pdf" target="_blank">analysis</a> by Melissa Barber of Harvard T. H. Chan School of Public Health and Dzintars Gotham of King’s College Hospital in London, "the cost of production for molnupiravir capsules is US$1.74 per unit, or US$17.74 per five-day regimen."</p><p></p><p>"Adding an allowance for 10% profit margin and taxes in India, we arrive at an estimated sustainable generic price of US$1.96 per capsule or US$19.99 per five-day regimen," the researchers concluded.</p><p></p><p>Dean Baker, a senior economist at the Center for Economic and Policy Research, noted that the $712 price-per-course price the U.S. government is set to pay for molnupiravir amounts to a roughly <a href="https://twitter.com/DeanBaker13/status/1444265498670026752" target="_blank">4,000% markup</a>.</p><p></p><p><em>Quartz</em>'s Annalisa Merelli <a href="https://qz.com/2068247/merck-could-make-up-to-7-billion-from-its-covid-19-drugs-in-2021/" target="_blank">reported</a> last week that with Merck expecting to produce 10 million courses of molnupiravir before the end of 2021, the company "could bring in revenue up to $7 billion."</p><p></p><p>"This would make it, in only a few weeks, one of the 10 most lucrative drugs ever," Merelli observed.</p><p></p><p>[URL unfurl="true"]https://www.commondreams.org/news/2021/10/06/entirely-unsurprising-merck-slammed-4000-markup-taxpayer-funded-covid-drug[/URL]</p></blockquote><p></p>
[QUOTE="dennishoddy, post: 3656247, member: 5412"] There was a news story today about the new "pill" that can be taken to treat off the covid if taken early floating around this morning. It costs penny's to make. The company, I believe it was Merck said they were going to market it at over $700. Meanwhile the generic of it is going to be sold in India at $19. Found it: [B]The New Jersey-based pharmaceutical[/B] giant Merck is facing accusations of price gouging after it charged the U.S. [URL='https://www.nytimes.com/2021/10/01/business/covid-antiviral-pill-merck.html']over $700 per patient[/URL] for a [URL='https://theintercept.com/2021/10/05/covid-pill-drug-pricing-merck-ridgeback/']taxpayer-funded[/URL] coronavirus treatment that, according to research, costs just $17.74 to produce. [B]Your tax dollars are paying for this even though brain dead biden says it's free if approved.[/B] Last week, Merck [URL='https://www.nbcnews.com/health/health-news/merck-says-experimental-covid-pill-cuts-risk-death-hospitalization-50-n1280536']announced[/URL] plans to request emergency federal authorization for molnupiravir after a late-stage clinical trial [URL='https://www.ft.com/content/e1a059dc-ab09-47c0-b7b9-2b79dd1c911b']showed[/URL] that a five-day course of the antiviral drug cut the risk of Covid-19 hospitalization or death in half in patients with mild-to-moderate cases. The same day Merck unveiled the results of the trial and White House officials hailed the drug as another possible tool against Covid-19, the [I]New York Times[/I] [URL='https://www.nytimes.com/2021/10/01/business/covid-antiviral-pill-merck.html']reported[/URL] that "the federal government has placed advance orders for 1.7 million courses of treatment, at a price of about $700 per patient"—far more than the estimated cost of manufacturing the drug. According to an [URL='https://scholar.harvard.edu/files/melissabarber/files/estimated_cost-based_generic_prices_for_molnupiravir_for_the_treatment_of_covid-19_infection.pdf']analysis[/URL] by Melissa Barber of Harvard T. H. Chan School of Public Health and Dzintars Gotham of King’s College Hospital in London, "the cost of production for molnupiravir capsules is US$1.74 per unit, or US$17.74 per five-day regimen." "Adding an allowance for 10% profit margin and taxes in India, we arrive at an estimated sustainable generic price of US$1.96 per capsule or US$19.99 per five-day regimen," the researchers concluded. Dean Baker, a senior economist at the Center for Economic and Policy Research, noted that the $712 price-per-course price the U.S. government is set to pay for molnupiravir amounts to a roughly [URL='https://twitter.com/DeanBaker13/status/1444265498670026752']4,000% markup[/URL]. [I]Quartz[/I]'s Annalisa Merelli [URL='https://qz.com/2068247/merck-could-make-up-to-7-billion-from-its-covid-19-drugs-in-2021/']reported[/URL] last week that with Merck expecting to produce 10 million courses of molnupiravir before the end of 2021, the company "could bring in revenue up to $7 billion." "This would make it, in only a few weeks, one of the 10 most lucrative drugs ever," Merelli observed. [URL unfurl="true"]https://www.commondreams.org/news/2021/10/06/entirely-unsurprising-merck-slammed-4000-markup-taxpayer-funded-covid-drug[/URL] [/QUOTE]
Insert Quotes…
Verification
Post Reply
Forums
The Water Cooler
General Discussion
Why wasn't this known sooner??? Covid drug around since 1979
Search titles only
By:
Top
Bottom